Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study. [electronic resource]
Producer: 20100319Description: 264-72 p. digitalISSN:- 1474-4465
- Adult
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- CD4-Positive T-Lymphocytes -- immunology
- CD8-Positive T-Lymphocytes -- immunology
- Cross-Sectional Studies
- Female
- Humans
- Immunity, Cellular -- immunology
- JC Virus -- immunology
- Leukoencephalopathy, Progressive Multifocal -- chemically induced
- Longitudinal Studies
- Lymphocyte Activation -- immunology
- Male
- Multiple Sclerosis -- drug therapy
- Natalizumab
- Prospective Studies
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.